<Previous Article In Issue
Volume 2, Issue 4, December 2020, Pages 173 - 175
COVID-19 in Hematologic Malignancies: Big Challenges
Authors
Yongxian Hu1, 2, 3, Linqin Wang1, 2, 3, 
, Qu Cui4, Elaine Tan Su Yin1, 2, 3, Hengwei Wu1, 2, 3, Arnon Nagler5, He Huang1, 2, 3, *
, Qu Cui4, Elaine Tan Su Yin1, 2, 3, Hengwei Wu1, 2, 3, Arnon Nagler5, He Huang1, 2, 3, *1Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
2Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
3Institute of Hematology, Zhejiang University, Hangzhou, China
4Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
5Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
*Corresponding author. Email: huanghe@zju.edu.cn
Corresponding Author
He Huang
Received 29 May 2020, Accepted 16 September 2020, Available Online 7 October 2020.
- DOI
- 10.2991/chi.k.200919.001How to use a DOI?
- Keywords
- COVID-19; hematological malignancies; clinical manifestation; treatment strategies
- Copyright
- © 2020 International Academy for Clinical Hematology. Publishing services by Atlantis Press International B.V.
- Open Access
- This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
Download article (PDF)
View full text (HTML)
<Previous Article In Issue
Cite this article
TY - JOUR AU - Yongxian Hu AU - Linqin Wang AU - Qu Cui AU - Elaine Tan Su Yin AU - Hengwei Wu AU - Arnon Nagler AU - He Huang PY - 2020 DA - 2020/10/07 TI - COVID-19 in Hematologic Malignancies: Big Challenges JO - Clinical Hematology International SP - 173 EP - 175 VL - 2 IS - 4 SN - 2590-0048 UR - https://doi.org/10.2991/chi.k.200919.001 DO - 10.2991/chi.k.200919.001 ID - Hu2020 ER -